511.69KMarket Cap
0.00P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of NewGenIvf Group Ltd
Currency: USD Updated: 2026-05-15 Key Insights
NewGenIvf Group Ltd's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered undervalued, ranking 63 out of 74 in the Healthcare Providers & Services industry.Institutional ownership is relatively high.Over the past month, multiple analysts have rated it as , with the highest price target at 900.00.In the medium term, the stock price is expected to trend down.
NewGenIvf Group Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
NewGenIvf Group Ltd Highlights
StrengthsRisks
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-15 The current financial score of NewGenIvf Group Ltd is 5.95, ranking 61 out of 74 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 1.42M, representing a year-over-year increase of 11.85%, while its net profit experienced a year-over-year increase of 6984.91%.
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Key Metrics
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Key Metrics
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Key Metrics
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Key Metrics
Relevant data have not been disclosed by the company yet.
NewGenIvf Group Ltd's Company Valuation
Currency: USD Updated: 2026-05-15The current valuation score of NewGenIvf Group Ltd is 7.62, ranking 24 out of 74 in the Healthcare Providers & Services industry. Its current P/E ratio is 0.00, which is 320602666.67% below the recent high of 961.81 and 82077166.67% above the recent low of -246.23.
Valuation Dimensions
Industry Ranking 63/74
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-15No earnings forecast score is currently available for NewGenIvf Group Ltd. The Healthcare Providers & Services industry's average is 7.57. The average price target is 75.00, with a high of 75.00 and a low of 75.00.
Support & Resistance
Relevant data have not been disclosed by the company yet.
No Data
Financial Forecasting
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-15No price momentum score is currently available for NewGenIvf Group Ltd. The Healthcare Providers & Services industry's average is 7.61.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Institutional Confidence
Currency: USD Updated: 2026-05-15Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
UBS Financial Services, Inc.
Two Sigma Investments, LP
BofA Global Research (US)
Risk Assessment
Currency: USD Updated: 2026-05-15The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of NewGenIvf Group Ltd is 1.04, ranking 68 out of 74 in the Healthcare Providers & Services industry. The company's beta value is -0.03. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Beta vs S&P 500 index
-0.06
240-Day Maximum Drawdown
+99.92%
240-Day Volatility
+232.51%
Volatility
Downside Risk-Adjusted Return
Maximum Daily Upside Volatility
Maximum Daily Downside Volatility
Healthcare Providers & Services
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Concentra Group Holdings Parent Inc
CON
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
